APA (7th ed.) Citation

H, Á., A, M., L, R., B, N., S, E., V, S., . . . JM, L. (2023). Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 77(4), 593. https://doi.org/10.1093/cid/ciad219

Chicago Style (17th ed.) Citation

H, Álvarez, et al. "Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 77, no. 4 (2023): 593. https://doi.org/10.1093/cid/ciad219.

MLA (9th ed.) Citation

H, Álvarez, et al. "Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 77, no. 4, 2023, p. 593, https://doi.org/10.1093/cid/ciad219.